Literature DB >> 1908484

Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.

J S Finkelstein1, R W Whitcomb, L S O'Dea, C Longcope, D A Schoenfeld, W F Crowley.   

Abstract

The precise sites of action of the negative feed-back effects of gonadal steroids in men remain unclear. To determine whether testosterone (T) administration can suppress gonadotropin secretion directly at the level of the pituitary, the pituitary responses to physiological doses of GnRH were assessed in six men with complete GnRH deficiency, whose pituitary-gonadal function had been normalized with long term pulsatile GnRH delivery, before and during a 4-day continuous T infusion (15 mg/day). Their responses were compared with the effects of identical T infusions on spontaneous gonadotropin secretion and the response to a 100-micrograms GnRH bolus in six normal men. Both groups were monitored with 15 h of frequent blood sampling before and during the last day of the T infusion. In the GnRH-deficient men, the first three GnRH doses were identical and were chosen to produce LH pulses with amplitudes in the midphysiological range of our normal men (i.e. a physiological dose), while the last four doses spanned 1.5 log orders (7.5, 25, 75, and 250 ng/kg). The 250 ng/kg dose was always administered last because it is known to be pharmacological. In the GnRH-deficient men, mean LH (P less than 0.02) and FSH (P less than 0.01) levels as well as LH pulse amplitude (P less than 0.05) decreased significantly during T infusion, demonstrating a direct pituitary-suppressive effect of T and/or its metabolites. Mean LH levels were suppressed to a greater extent in the normal than in the GnRH-deficient men (58 +/- 15% vs. 28 +/- 7%; P less than 0.05). In addition, LH frequency decreased significantly (P less than 0.01) during T administration in the normal men. These latter two findings suggest that T administration also suppresses hypothalamic GnRH release. T was unable to suppress gonadotropin secretion in one GnRH-deficient and one normal man. In both groups, the suppressive effect of T administration was present only in response to physiological doses of GnRH. Because the pituitary- and hypothalamus-suppressive effects of T could be mediated by its aromatization to estrogens, five GnRH-deficient and five normal men underwent identical T infusions with concomitant administration of the aromatase inhibitor testolactone (TL; 500 mg, orally, every 6 h). As an additional control, four GnRH-deficient and four normal men received TL alone. TL administration completely prevented the effect of T administration to suppress gonadotropin secretion in both the normal and GnRH-deficient men, and mean LH levels increased significantly in both the GnRH-deficient (P less than 0.01) and the normal (P less than 0.001) men who received TL alone. The increase in mean LH levels was greater (P less than 0.01) in the normal men who received TL alone than in the normal men who received T plus TL, thus revealing a direct effect of androgens in normal men. Measurements of T and estradiol production rates in three men demonstrated that TL effectively blocked aromatization.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908484     DOI: 10.1210/jcem-73-3-609

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Potential diagnostic utility of intermittent administration of short-acting gonadotropin-releasing hormone agonist in gonadotropin deficiency.

Authors:  Carrie A Zimmer; David A Ehrmann; Robert L Rosenfield
Journal:  Fertil Steril       Date:  2010-05-31       Impact factor: 7.329

2.  Biphasic testosterone delivery profile observed with two different transdermal formulations.

Authors:  A Misra; R Pal; S S Majumdar; G P Talwar; O Singh
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

Review 3.  Testosterone hormone replacement therapy: state-of-the-art and emerging technologies.

Authors:  Marie-Laure Leichtnam; Hervé Rolland; Patrick Wüthrich; Richard H Guy
Journal:  Pharm Res       Date:  2006-06-09       Impact factor: 4.200

4.  Androgens block outward potassium currents and decrease spontaneous action potentials in GH3 cells.

Authors:  Lorena Suárez; Usama Bilal; Javier Bordallo; Begoña Cantabrana; Manuel Sánchez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-26       Impact factor: 3.000

5.  Aromatase inhibition causes increased amplitude, but not frequency, of hypothalamic-pituitary output in normal women.

Authors:  Alexander Kucherov; Alex J Polotsky; Marie Menke; Barbara Isaac; Beth McAvey; Erkan Buyuk; Andrew P Bradford; Cheryl Hickmon; Beatrice Babbs; Sarah Berga; Tammy Loucks; Nanette Santoro
Journal:  Fertil Steril       Date:  2011-02-26       Impact factor: 7.329

Review 6.  GnRH pulsatility, the pituitary response and reproductive dysfunction.

Authors:  Rie Tsutsumi; Nicholas J G Webster
Journal:  Endocr J       Date:  2009-07-17       Impact factor: 2.349

7.  Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.

Authors:  M Y Roth; J J S Nya-Ngatchou; K Lin; S T Page; B D Anawalt; A M Matsumoto; B T Marck; W J Bremner; J K Amory
Journal:  J Clin Endocrinol Metab       Date:  2013-01-24       Impact factor: 5.958

8.  Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men.

Authors:  Nelly Pitteloud; Andrew A Dwyer; Suzzunne DeCruz; Hang Lee; Paul A Boepple; William F Crowley; Frances J Hayes
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

Review 9.  Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.

Authors:  J E Hall; A E Taylor; F J Hayes; W F Crowley
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

10.  The relative role of gonadal sex steroids and gonadotropin-releasing hormone pulse frequency in the regulation of follicle-stimulating hormone secretion in men.

Authors:  Nelly Pitteloud; Andrew A Dwyer; Suzzunne DeCruz; Hang Lee; Paul A Boepple; William F Crowley; Frances J Hayes
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.